{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:19:28Z","timestamp":1785007168796,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100030622","name":"UNC Department of Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijrobp.2026.02.194","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:23:36Z","timestamp":1771374216000},"page":"222-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features Following Radical Prostatectomy"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-0438","authenticated-orcid":false,"given":"Carlos E.","family":"Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly M.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Niska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer R.","family":"Keole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Rwigema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.194_bib0001","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer - 29-year follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0002","first-page":"65","article-title":"Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study","volume":"172","author":"Iversen","year":"1995","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0004","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0005","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0006","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): A randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0007","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): A randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0008","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): A randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0009","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2024.05.014","article-title":"Stereotactic body proton therapy versus conventionally fractionated proton therapy for early prostate cancer: A randomized, controlled, phase 3 trial","volume":"120","author":"Toesca","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0011","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0012","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/cancers14030696","article-title":"Stereotactic radiotherapy after radical prostatectomy in patients with prostate cancer in the adjuvant or salvage setting: A systematic review","volume":"14","author":"Schroder","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib38","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.euo.2023.03.005","article-title":"Salvage stereotactic reirradiation for local recurrence in the prostatic bed after prostatectomy: A retrospective multicenter study","volume":"6","author":"Archer","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2022.08.041","article-title":"Quality-of-life outcomes and toxicity profile among patients with localized prostate cancer after radical prostatectomy treated with stereotactic body radiation: The scimitar multicenter phase 2 trial","volume":"115","author":"Ma","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaoncol.2025.1059","article-title":"Patient-reported outcomes with stereotactic intensity modulated radiotherapy after radical prostatectomy: A nonrandomized clinical trial","volume":"11","author":"Nikitas","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0016","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.3390\/curroncol29120733","article-title":"Acute toxicity and quality of life in a post-prostatectomy ablative radiation therapy (POPART) multicentric trial","volume":"29","author":"Lucchini","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0017","article-title":"Preliminary analysis of a phase ii trial of stereotactic body radiation therapy for prostate cancer with high-risk features after radical prostatectomy","volume":"8","author":"Laughlin","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0018","doi-asserted-by":"crossref","first-page":"252.e1","DOI":"10.1016\/j.urolonc.2022.12.001","article-title":"Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer","volume":"41","author":"Ozyigit","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111072","article-title":"Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence","volume":"211","author":"Ferrario","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0020","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1007\/s12094-025-03845-w","article-title":"SABR tolerance after prostatectomy: Pushing the boundaries of ultrahypofractionation","volume":"27","author":"Montero","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0021","first-page":"1712","article-title":"A randomized controlled phase 2 trial comparing salvage radiotherapy for prostate cancer delivered in 4 versus 2 weeks (shorter): Acute genitourinary and gastrointestinal patient-reported outcomes at a single institution","volume":"8","author":"Nagar","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0022","article-title":"ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer","volume":"41","author":"Dal Pra","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0024","unstructured":"U.S. Department of Health And Human Services; National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. 2017."},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0026","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ijrobp.2025.07.1416","article-title":"Long-term results of NRG\/RTOG 9601, a randomized trial of radiation with or without antiandrogens in patients receiving salvage prostate bed radiation therapy postprostatectomy","volume":"123","author":"Lukka","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11934-019-0918-0","article-title":"Hypofractionated radiotherapy for localized prostate cancer: When and for whom?","volume":"20","author":"Roy","year":"2019","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bju.14924","article-title":"Stereotactic radiotherapy for prostate bed recurrence after prostatectomy, a multicentric series","volume":"125","author":"Francolini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fonc.2019.00071","article-title":"Stereotactic re-irradiation for local recurrence in the prostatic bed after prostatectomy: Preliminary results","volume":"9","author":"Olivier","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00345-015-1613-5","article-title":"Cyberknife stereotactic radiotherapy for isolated recurrence in the prostatic bed","volume":"34","author":"Detti","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0031","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.5301\/tj.5000251","article-title":"Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed","volume":"101","author":"Arcangeli","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0032","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12885-022-09493-5","article-title":"Phase III randomised controlled trial on PSMA PET\/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): Study protocol","volume":"22","author":"Staal","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0033","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0034","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2018.12.047","article-title":"Phase 1 trial of SBRT to the prostate fossa after prostatectomy","volume":"104","author":"Ballas","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2019.11.005","article-title":"Stereotactic body radiation therapy to the prostate bed: Results of a phase 1 dose-escalation trial","volume":"106","author":"Sampath","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0036","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaoncol.2020.7671","article-title":"Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: An ancillary study of the NRG\/RTOG 9601 randomized clinical trial","volume":"7","author":"Feng","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.194_bib0037","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(24)00549-X","article-title":"Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: A comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial","volume":"403","author":"Parker","year":"2024","journal-title":"Lancet"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:31:09Z","timestamp":1782030669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626003287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0360301626003287"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.194","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features Following Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}